April C May
Overview
Explore the profile of April C May including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
May A, Burrows K, Figueroa-Hall L, Kirlic N, White E, Smith R, et al.
Drug Alcohol Depend
. 2021 May;
224:108743.
PMID: 34024664
No abstract available.
12.
May A, Burrows K, Figueroa-Hall L, Kirlic N, White E, Smith R, et al.
Drug Alcohol Depend
. 2021 Feb;
221:108610.
PMID: 33631550
Background: Substance use disorders (SUD) with comorbid depression and anxiety are linked to poor treatment outcome and relapse. Although some depressed individuals exhibit elevated blood-based inflammation (interleukin-6 [IL-6] and C...
13.
May A, Jacobus J, Stewart J, Simmons A, Paulus M, Tapert S
Brain Sci
. 2020 Apr;
10(4).
PMID: 32260480
Alcohol and cannabis use are highly prevalent among adolescents and associated with negative consequences. Understanding motivations behind substance use in youth is important for informing prevention and intervention efforts. The...
14.
May A, Aupperle R, Stewart J
Front Psychiatry
. 2020 Apr;
11:114.
PMID: 32256392
Methamphetamine use is associated with substantial adverse outcomes including poor mental and physical health, financial difficulties, and societal costs. Despite deleterious long-term consequences associated with methamphetamine, many people use drugs...
15.
Stewart J, May A, Paulus M
Neuroimage Clin
. 2019 Dec;
24:102068.
PMID: 31795056
Recent methamphetamine and opioid use epidemics are a major public health concern. Chronic stimulant and opioid use are characterized by significant psychosocial, physical and mental health costs, repeated relapse, and...
16.
Stewart J, May A, Aupperle R, Bodurka J
Front Psychiatry
. 2019 Mar;
10:117.
PMID: 30899231
The United States is in the midst of an opioid epidemic and lacks a range of successful interventions to reduce this public health burden. Many individuals with opioid use disorder...
17.
Gowin J, Ernst M, Ball T, May A, Sloan M, Tapert S, et al.
Neuroimage Clin
. 2019 Jan;
21:101676.
PMID: 30665102
Objective: Relapse rates are consistently high for stimulant user disorders. In order to obtain prognostic information about individuals in treatment, machine learning models have been applied to neuroimaging and clinical...
18.
Blair M, Stewart J, May A, Reske M, Tapert S, Paulus M
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2018 Apr;
3(11):947-958.
PMID: 29681519
Background: Occasional recreational stimulant (amphetamine and cocaine) use is an important public health problem among young adults because 16% of those who experiment develop stimulant use disorder. This study aimed...
19.
Stewart J, Butt M, May A, Tapert S, Paulus M
Addiction
. 2017 Apr;
112(9):1567-1577.
PMID: 28387975
Aims: To understand processes placing individuals at risk for stimulant (amphetamine and cocaine) use disorder. Design: Longitudinal study. Setting: University of California, San Diego Department of Psychiatry, CA, USA. Participants:...
20.
McKinnon S, Holloway B, Santoro M, May A, Cronan T
Calif J Health Promot
. 2017 Feb;
14(3):45-57.
PMID: 28217035
Background And Purpose: The projected increase in chronically ill older adults may overburden the healthcare system and compromise the receipt of quality and coordinated health care services. Healthcare advocates (HCAs)...